Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMC4 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | GLTPD2 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
mRNA | PRDM13 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
mRNA | FUK | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
mRNA | FBXO40 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
mRNA | IRF5 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | BRCC3 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
mRNA | TBC1D32 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
mRNA | ID3 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | ADAT2 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |